Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Clinical trial NCT01585805 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01585805
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-15
- Primary completion
- 2024-12-31
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.